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Abstract
Antibiotic use during adolescence may result in dysbiosis-induced neuronal vulnerability
both in the enteric nervous system (ENS) and central nervous system (CNS) contributing to
the onset of chronic gastrointestinal disorders, such as irritable bowel syndrome (IBS),
showing significant psychiatric comorbidity. Intestinal microbiota alterations during adoles-
cence influence the expression of molecular factors involved in neuronal development in
both the ENS and CNS. In this study, we have evaluated the expression of brain-derived
neurotrophic factor (BDNF) and its high-affinity receptor tropomyosin-related kinase B
(TrkB) in juvenile mice ENS and CNS, after a 2-week antibiotic (ABX) treatment. In both
mucosa and mucosa-deprived whole-wall small intestine segments of ABX-treated animals,
BDNF and TrKB mRNA and protein levels significantly increased. In longitudinal muscle-
myenteric plexus preparations of ABX-treated mice the percentage of myenteric neurons
staining for BDNF and TrkB was significantly higher than in controls. After ABX treatment, a
consistent population of BDNF- and TrkB-immunoreactive neurons costained with SP and
CGRP, suggesting up-regulation of BDNF signaling in both motor and sensory myenteric
neurons. BDNF and TrkB protein levels were downregulated in the hippocampus and
remained unchanged in the prefrontal cortex of ABX-treated animals. Immunostaining for
BDNF and TrkB decreased in the hippocampus CA3 and dentate gyrus subregions, respec-
tively, and remained unchanged in the prefrontal cortex. These data suggest that dysbiosis
differentially influences the expression of BDNF-TrkB in the juvenile mice ENS and CNS.
Such changes may potentially contribute later to the development of functional gut disor-
ders, such as IBS, showing psychiatric comorbidity.
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Introduction
Numerous studies have established that the naturally occurring commensal microbiota, which
in the human gut is composed of about 3.8X 1013 bacterial cells belonging to approximately
2000 species, represents an essential organ for the host homeostasis by contributing to the
metabolism of nutrients, development of the immune host defence and maturation of the gas-
trointestinal (GI) tract [1]. The complex array of cellular elements constituting the enteric
microenvironment (enterocytes, enteroendocrine cells, immunocytes, smooth muscle cells,
interstitial Cajal cells, enteric neurons and glial cells) responds to microbial factors, mainly via
pattern recognition receptors (e.g. Toll-like receptors, TLRs) [2,3], neurotransmitter, neuro-
peptides and neurohormone receptors [4–6]. The commensal gut microbial flora influences
the development and function of the enteric nervous system (ENS), which consists of two
complex interconnected neuroglial networks, constituting the submucosal and myenteric
plexus [7]. Microbiota-induced neuronal plasticity is, however, not limited to the ENS but can
potentially activate responses in the central nervous system (CNS), via activation of neuroen-
docrine and metabolic pathways, along the microbiota-gut-brain axis [8]. Several preclinical
studies, carried out in animals fed with specific dietary regimens and in transgenic animals or
germ-free (GF) rodents, have shown that dysfunction of the gut microbiota during early life
(infancy, childhood and adolescence) has important consequences, not only on the normal gut
functions, but also on the brain and behaviour, including pain perception, stress response and
anxiety [9]. During adolescence neurons undergo crucial structural, neurochemical and
molecular changes in response to genetic and environmental signals both in the CNS and in
the ENS [10,11]. During this stage of life, the symbiotic microbial flora experiences dynamic
processes, such as changes in the composition and relative abundance of various microbial
constituents, which may influence neuronal development [11,12]. Environmental insults, such
as the use of antibiotics, stress, harmful events and poor diet, may result in dysbiosis-induced
neuronal vulnerability both in the ENS and CNS. This neuronal susceptibility to microbiota
alterations contributes to the onset of chronic functional GI disorders, such as irritable bowel
syndrome (IBS), which is associated with psychological distress and psychiatric comorbidity,
including depression [9, 13]. From this perspective, it is important to evaluate whether changes
in the symbiotic microbial flora during adolescence may influence the expression of some fac-
tors involved in neuronal development and plasticity both in the ENS and CNS. In this study,
we have focused on the role of brain-derived neurotrophic factor (BDNF) and its high affinity
receptor tropomyosin-related kinase B (TrkB). BDNF plays a central role in promoting neuro-
nal survival and growth, synaptic plasticity and reinforcement of synaptic communication
[14,15]. In the CNS, the neurotrophin is a key molecule influencing mood, behaviour and cog-
nitive functions, such as learning and memory, and any alteration of its levels are related to
development of psychiatric disorders, such as anxiety and depression [16,17]. The normal gut
microbiota influences the expression of BDNF in brain regions crucially involved in the devel-
opment of correct behavioral patterns, such as the hippocampus and cortex [18,19]. A relation-
ship between development of behavioral disorders, such as anxiety and cognitive deficits, and
altered BDNF levels in different CNS regions was demonstrated both in GF mice and in ado-
lescent mice after antibiotic treatment-induced dysbiosis [20–22]. In the GI tract, BDNF is
released from different cell types, including enterocytes, enteric glial cells and neurons and
plays a fundamental role in modulating both sensory and motor functions [23–26]. BDNF rep-
resents a neurotransmitter/neuromodulator in enteric neuronal circuitries, favouring the local
release of enteroendocrine molecules and neurotransmitters from sensory and motor neurons,
enhancing peristalsis and gut motility both in laboratory animals and in humans [23,24,27,28].
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The neurotrophin plays also a modulatory role on visceral pain perception, as demonstrated in
studies carried out on rat models of IBS showing that BDNF may favour the development of
visceral hypersensitivity by activating both intrinsic and extrinsic primary afferent neurons
[25,29]. In addition, BDNF released from dorsal root ganglia and spinal cord contributed to
the development of exaggerated visceromotor responses to colorectal distension in a rat model
of colitis [30]. In spite, of the central role played by BDNF in the microbiota-gut-brain axis,
there are no reports, at least up to our knowledge, concerning the occurrence of BDNF and
TrkB expression changes in the ENS, caused by alterations in the gut commensal microflora
during adolescence. The demonstration of such relationship would be, even more, interesting
since, in the ENS of juvenile mice, important rearrangements of both excitatory and inhibitory
neurotransmitter pathways regulating intestinal motility occur after antibiotic-induced dys-
biosis [31]. Thus, the aim of this study was to evaluate the expression of BDNF and TrkB in the
ENS of juvenile mice after a massive chronic antibiotic treatment, by means of morphological
and molecular biology approaches. In view of the ability of the gut microbiota to influence
neurotrophin expression in the CNS, we also investigated BDNF and TrkB levels in the hippo-
campus and prefrontal cortex.
Materials and methods
Animals
Juvenile male C57BL/6J mice (3±1 week-old, body weight 18±1 g, Charles River Laboratories,
Italy) were housed in groups of four animals in individually ventilated cages with sawdust on
bottom, under controlled environmental conditions (temperature 21±1˚C; relative humidity
60–70%). Animals had free access to a standard laboratory chow and tap water and were main-
tained at a regular 12/12-h light/dark cycle. Animal care and handling were in accordance with
the European Union Council Directive 2010/63, recognized and adopted by the Italian Gov-
ernment (Decree No. 26/2014). The protocol was approved by the Animal Care and Use Ethics
Committee of the University of Padova and University of Insubria and by the Italian Ministry
of Health (Ref n. 1142/2015-PR).
Animal treatment
Gut dysbiosis was induced in adolescent mice according to a previously described pharmaco-
logical procedure, which reproduces a germ free-like phenotype [31]. Briefly, a cocktail of
broad-spectrum antibiotics (50 mg/kg vancomycin, 100 mg/kg neomycin, 100 mg/kg metroni-
dazole and 100 mg/kg ampicillin, ABX-treated mice group), was administered to conscious
mice every 12 hours for 14 days by oral gavage (100 μl/mouse), using a stainless-steel feeding
tube [31]. Tap water was administered as vehicle to control (CTR) mice. Animals were ran-
domized to treatment groups. To normalize gut microbiota, mice colonies from both groups
were housed in the same room and generally in the same cages and maintained by the same
personnel. At the end of procedures, animals were euthanized by cervical dislocation. The
small intestine was removed and washed with a physiological Krebs solution (composition in
mM: NaCl 118, NaHCO3 25, glucose 11, KCl 4.7, CaCl2�2H2O 2.5, MgSO4�7H2O 1.2, K2HPO4
1.2). For western blot and qRT-PCR analysis, experiments were carried out separately on the
mucosa and mucosa-deprived whole wall segments. Western blot and qRT-PCR analysis
experiments were carried out on the prefrontal cortex and hippocampus. Tissues collected for
western blotting and qRT-PCR analyses were kept at -80˚C until the experiments were per-
formed. For immunofluorescence staining intestinal segments, prefrontal cortex and hippo-
campus were fixed immediately after collection.
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Immunofluorescence
The immunolocalization of BDNF and TrkB was performed on paraffin-embedded prefrontal
cortex and hippocampus sections and on longitudinal muscle myenteric plexus (LMMP)
whole-mount preparations obtained from the small intestine of ABX-treated and CTR mice.
Paraffin sections. The prefrontal cortex and hippocampus were dissected and postfixed
at 4˚C in 4% paraformaldehyde in phosphate buffer: (PBS composition in mM: 0.14 NaCl,
0.003 KCl, 0.015 Na2HPO4, 0.0015 KH2PO4, pH 7.4) for 4 hours. Brain regions were treated
for 72 h in sucrose 30% v/v in PBS and embedded in paraffin. Cross sections (7 μm) of both
ABX-treated and CTR samples were processed as described by Filpa et al. [32]. The details of
the primary and secondary antibodies and related optimal dilution are reported in Table 1.
PBS buffer used for washing steps and primary antibodies dilutions contained 2% bovine
serum albumin (BSA). Control samples were incubated with 2% BSA in PBS. Coverslips were
mounted with Citifluor mounting medium and then observed under a fluorescence micro-
scope (Nikon Instruments).
Whole-mounts. For whole-mount immunolabelling, small intestine segments were fixed
with 0.2 mol/l PBS containing 4% formaldehyde and 0.2% picric acid and the longitudinal
muscle with the attached myenteric plexus (LMMP) was gently removed from the rest of the
intestinal wall as previously described [33]. After blocking nonspecific sites for 2 hours using
PBS with added 1% Triton X-100 and 10% normal horse serum (NHS) (Euroclone, Pero,
Italy), LMMPs were incubated with optimally diluted primary antibodies (Table 1). Double-
labeling was performed during consecutive incubation times: the first primary antibody was
added overnight at 4˚C, then incubation with the appropriate secondary antibody followed for
2h at room temperature (RT). Preparations were successively incubated overnight at 4˚C with
the second primary antibody and for 2 h at RT with an appropriate secondary antibody.
Table 1. Primary and secondary antisera and their respective dilutions used for immunohistochemistry (HC) and western blot (WB) assay.
Antiserum Dilution(WB) Dilution(HC) Source Hostspecies
Primary antisera
HUC/D, biotin ______ 1:100 Invitrogen (A-21272) Mouse
TrkB 1:100 1: 50 Santa Cruz (sc8316) Rabbit
TrkB ______ 1: 50 Santa Cruz (sc377218) Mouse
Phospho-TrKB (Tyr816) 1:200 ______ Millipore (ABN1381) Rabbit
BDNF 1:200 1:50 Santa Cruz (sc546) Rabbit
BDNF ______ 1:50 Santa Cruz (sc65514) Mouse
CGRP ______ 1:200 Immunostar (24112) Rabbit
Substance P ______ 1:200 Immunostar (20064) Rabbit
β-actin 1:1000 _______ Cell Signalling Technology (#3700) Mouse
Secondary antisera & streptavidin complexes
Anti-rabbit Alexa Fluor 488 ______ 1:300 Molecular Probes (A21206) Donkey
Anti-mouse Alexa Fluor 488 ______ 1:300 Molecular Probes (A21202) Donkey
Cy3-conjugated streptavidin ______ 1:500 Amersham (PA43001) ______
F(ab’)2 Anti-rabbit IgG (H+L) biotin ______ 1:300 Caltag laboratories (L43015) Goat
Anti-rabbit IgG HRP peroxidase conjugated 1:10000 ______ Amersham (NA934) Donkey
Anti-mouse IgG, HRP- linked 1:2000 ______ Cell Signalling Technology (#7076) Horse
Supplying companies: Amersham, GE Healthcare, Buckinghamshire, UK; Caltag Laboratories, Invitrogen, Burlingame, CA, USA; Cell Signaling Technology, Danvers,
Massachusetts, USA; Immunostar Inc., Hudson, WI; Millipore, Temecula, CA; Molecular Probes, Invitrogen, Carlsbad, CA, USA; Santa Cruz Biotechnology Inc., CA,
USA.
https://doi.org/10.1371/journal.pone.0212856.t001
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Preparations were mounted onto glass slides, using a mounting medium (Vectashield; Vector
Lab, Burlingame, CA, USA). Total neuron number per ganglion area was expressed as the
ratio between the number of HuC/D-immunoreactive (IR) neurons within the ganglion and
the total ganglion area (μm2) measured with Image J NIH image software (http://imagej.nih.
gov/ij). Neuronal cell body area was also measured and analyzed with Image J. Confocal
images of 15 ganglia captured from preparations obtained from ABX-treated and CTR groups,
respectively, were used both for neuronal cell counting and ganglia area measurement. To
establish the proportion of BDNF- and TrkB-expressing myenteric neurons, the number of
BDNF-IR or TrkB-IR neurons that co-localized with HuC/D were counted and expressed as
percentage of the total number of HuC/D-IR neurons [34]. Since BDNF and TrkB are known
to co-localize with some neuropeptides, some experiments were carried out to evaluate a possi-
ble co-immunostaining with substance P (SP) or calcitonin related-gene peptide (CGRP)
[24,35]. A total of 10–20 ganglia were sampled from LMMP preparations obtained from 5 ani-
mals for each experimental group. Negative controls and interference control staining were
evaluated by omitting both the primary and/or the secondary antibody, and by incubating
colonic whole-mount preparations with nonimmune serum from the same species in which
the primary antibodies were raised. No specific signal was detected under any of these condi-
tions. Preparations were analyzed using a Leica TCS SP5 confocal laser scanning system (Leica
Microsystems GmbH, Wetzlar, Germany) and pictures were processed with Adobe-Photoshop
CS6S software.
Real-time quantitative RT-PCR
Total RNA was extracted from small intestine mucosa and mucosa-deprived whole wall, pre-
frontal cortex and hippocampus samples with TRIzol and treated with DNase I (DNase Free) to
remove any traces of contaminating DNA. cDNA was obtained by retrotranscribing 2 μg of total
RNA using the High Capacity cDNA synthesis kit (Applied Biosystems, Milan, Italy). Quantita-
tive RT-PCR was performed on the Abi Prism 7000 real-time thermocycler (Applied Biosystems,
Milan, Italy) with Power Sybr Green Universal PCR Master Mix (Applied Biosystems, Milan,
Italy) according to the manufacturer’s instructions. Primers were designed using Primer Express
software (Applied Biosystems, Milan, Italy) as reported in Table 2 and a final concentration of
500 nM for each primer was used. Primers were designed to have a similar amplicon size and
similar amplification efficiency as required for applying the 2-ΔΔCt method to compare gene
expression in the ABX-treated group with respect to CTR values [36]. β-actin was used as house-
keeping gene. Experiments were performed at least five times for each different preparation.
Western immunoblot analysis
Hippocampus, prefrontal cortex, small intestine mucosa and mucosa-deprived whole wall
samples were used to analyze BDNF and TrkB protein levels. Briefly, purified membrane
Table 2. Sequence of primers used in the study for the qRT-PCR analysis.
gene Sequence
β-actin F 5’-ACCAGAGGCATACAGGGACA-3’
R 5’-CTAAGGCCAACCGTGAAAAG-3’
HuC/D F 5’- AAGAGTCCCCTGTCGCTCA -3’
R 5’- TACACGAAGATGCACCAGCC -3’
BDNF F 5’- AACCATAAGGACGCGGACTT -3’
R 5’- TGCAGTCTTTTTATCTGCCG -3’
TrKB F 5’- CAGCACCAAGCAGCAAGAG -3’
R 5’- CAAGACCAGCAGGCATAAGC -3’
https://doi.org/10.1371/journal.pone.0212856.t002
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fractions were obtained after successive centrifugations, boiled for 5 min in Laemmli sample
buffer and processed for electrophoretic separation and blotting as described by Filpa et al.
[37]. Membrane incubation with BDNF or TrkB primary antibodies was followed by incuba-
tion with a horseradish peroxidase-conjugated secondary antiserum (Table 1). The antibody/
substrate complex was visualized by chemiluminescence using an enhanced chemilumines-
cence kit (ECL advance Amersham Pharmacia Biotech, Cologno Monzese, Italy). Signal inten-
sity was evaluated by densitometric analysis using Image J NIH image software. β-actin and α-
tubulin were used as protein loading control for intestinal and CNS areas, respectively. BDNF
or TrkB protein levels were expressed as the ratio of the optical density (expressed in arbitrary
units) of BDNF and TrkB bands and the optical density of the relevant β-actin or α-tubulin
band x1000 obtained in CTR and ABX-treated samples. Experiments were performed at least
five times. Negative controls were performed by omitting the primary antibody.
Statistical analysis
All data are expressed as mean±S.E.M. Statistical significance was calculated with applying the
unpaired Student’s t test, using GraphPad Prism (version 5.3 GraphPad software, San Diego,
CA, USA). The differences between groups were considered significant when P values
were< 0.05.
Results
BDNF mRNA and protein levels in the mouse small intestine of control
and ABX-treated mice
qRT-PCR analysis revealed a significant increase of BDNF transcript both in the mucosa
(p<0.001) and in mucosa-deprived whole intestinal wall (p<0.05) of ABX-treated mice as
reported in panels A and C, respectively, of Fig 1. In mouse small intestine preparations, west-
ern blot analysis of BDNF revealed a specific band at 28 kDa. In some samples a double band
was also observed, which may represent a post-translational change in the protein [38]. After
antibiotic-induced dysbiosis, BDNF protein levels increased significantly both in the mucosal
layer (p<0.05) and in the mucosa-deprived whole intestinal wall (p<0.05) (Fig 1, panels B
and D).
Distribution of BDNF in small intestine LMMP whole-mount preparations
from control and ABX-treated animals
In control small intestine LMMP whole-mount preparations, BDNF antibody faintly stained
the cytoplasm of few myenteric neurons (7.46±0.72%, n = 18) (Fig 2, panel G). As observed
after costaining with the pan-neuronal marker HuC/D, BDNF antibody stained the soma of
large and medium-sized neurons with either a round or an ovoidal shape. In myenteric gan-
glia, BDNF immunoreactivity was also found in prolongations discontinuously surrounding
neurons, in interconnecting strands between ganglia and in bundles of fibers running along
the longitudinal smooth muscle (Fig 2 panels A-C and D-F). A significant (p<0.0001) increase
in the number of BDNF-IR myenteric neurons was observed in ABX preparations with respect
to preparations obtained from CTR mice (Fig 2, panels D, F and G). In whole-mount LMMP
preparations obtained from both CTR and ABX-treated mice, BDNF-IR neurons co-stained
with SP (Fig 3, panels A-C). Intense SP immunoreactivity was also detected in varicose fibres
surrounding myenteric neurons, (Fig 3, panels B-C). After antibiotic treatment the number of
myenteric neurons co-expressing BDNF and SP increased significantly with respect to CTR
preparations [51.91±7.52% (n = 13); 10.69±4.97% (n = 12), respectively; p<0.001]. In both
Dysbiosis upregulates BDNF and TrkB expression in adolescent mice gut
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Fig 1. Expression of BDNF in juvenile mouse small intestine after antibiotic treatment-induced dysbiosis. (A, C)
RT-PCR quantification of BDNF transcripts in preparations of the mouse mucosa (A) and mucosa-deprived whole
wall (C) of the mouse small intestine obtained from control (CTR, empty bars) and ABX-treated (ABX, black bars).
Values are mean±S.E.M. of 9 experiments of the percentage variation of relative gene expression with respect to values
obtained in CTR animals. The relative gene expression was determined by comparing 2-ΔΔCt values normalized to β-
actin. (B, D) BDNF protein expression analyzed in the mucosa (B) and mucosa-deprived whole wall (D) of the mouse
small intestine obtained from CTR (empty bars) and ABX-treated animals (black bars). Blots representative of
immunoreactive bands for BDNF and β-actin in the different experimental conditions are reported on top of each
panel. Samples (200 μg) were electrophoresed in SDS-8% polyacrylamide gels. Numbers at the margins of the blots
indicate relative molecular weights of the respective protein in kDa. Values are expressed as mean±S.E.M. of 5
experiments of the ratio x1000 of the optical density (O.D.) of BDNF vs β-actin in CTR and in ABX-treated
preparations. �P<0.05 and ���P<0.001 vs CTR animals by unpaired Student’s t test.
https://doi.org/10.1371/journal.pone.0212856.g001
Fig 2. Effect of antibiotic treatment on BDNF distribution in juvenile mouse small intestine LMMP whole-mount preparations.
Representative confocal microphotographs showing co-staining of BDNF (green) and HuC/D (pan-neuronal marker, red) in LMMPs obtained
from CTR (A-C) and ABX-treated mice (D-F). In LMMPs obtained from both CTR and ABX-treated mice BDNF stained the soma of both large
and medium size neurons with either a round or an ovoidal shape (arrow). BDNF staining was also observed in prolongation surrounding neurons
and in the interconnecting fibers between ganglia (asterisk). In CTR preparations, BDNF faintly stained the soma of few neurons. After antibiotic
treatment, the number of BDNF positive myenteric neurons was significantly higher than in CTR (D-E). Bars: 50 μm. (G) Percentage of BNDF
immunoreactive myenteric neurons in small intestine of CTR and ABX-treated mice. Values are given as mean ± SEM of at least 20 fields for each
intestinal region.���P<0.001 vs CTR animals by unpaired Student’s t test vs CTR.
https://doi.org/10.1371/journal.pone.0212856.g002
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CTR and ABX-treated whole-mount preparations BDNF-IR myenteric neurons were also
immunoreactive to CGRP (Fig 3, panels D-F). CGRP immunoreactivity was also found in
dense varicose fibres surrounding myenteric neurons (Fig 3, panels E-F). The percentage of
BDNF-IR/CGRP-IR myenteric neurons in CTR preparations was 8.33±4.95% (n = 15) and sig-
nificantly increased in preparations obtained from ABX-treated animals [40.52±4.08%
(n = 16); p<0.0001]
TrkB mRNA and protein levels in the mouse small intestine of control and
ABX-treated mice
TrkB mRNA levels in mucosa and mucosa-deprived whole intestinal wall specimens signifi-
cantly increased (p<0.001 and p<0.0001, respectively) after antibiotic treatment as reported in
Fig 4, panels A and D, respectively. In mouse small intestine preparations, western blot analy-
sis of TrkB revealed a band at 145 kDa. In ABX-treated mice, TrkB protein levels significantly
increased both in the mucosa (p<0.05) and in mucosa-deprived whole intestinal wall (p<0.05)
(Fig 4, panels B and E). In both layers, the levels of TrkB phosphorylated on Tyr816 signifi-
cantly increased (p<0.05) (Fig 4, panels C and F).
Distribution of TrkB in small intestine LMMP whole-mount preparations
from control and ABX-treated animals
In control small intestine LMMP whole-mount preparations, TrkB antibody stained few neu-
rons (10.13±1.11%, n = 20) (Fig 5, panel G). As observed after co-staining with the pan
Fig 3. Relationship between BDNF, SP and CGRP immunoreactivity in juvenile mouse small intestine myenteric ganglia after antibiotic
treatment. (A-C) Representative micrographs of juvenile mouse small intestine LMMP whole-mount preparations obtained from ABX-treated mice
showing co-localization of BDNF and SP. BDNF immunoreactivity was found in the soma of a population of SP-IR expressing neurons (arrows).
BDNF-IR myenteric neurons were surrounded by varicose SP-IR fibers (asterisk). (D-F) Representative micrographs of mouse small intestine LMMP
whole-mount preparations obtained from ABX-treated mice showing co-localization of BDNF and CGRP. CGRP-IR was found in the soma (arrows)
of BDNF-IR myenteric neurons. BDNF-IR myenteric neurons were surrounded by varicose CGRP-IR fibers (asterisk). Bars: 25 μm.
https://doi.org/10.1371/journal.pone.0212856.g003
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neuronal marker, HuC/D, TrkB antibody stained the soma of large and medium-sized neu-
rons with prevalently an ovoidal shape. In myenteric ganglia, TrkB immunoreactivity was also
found in prolongations discontinuously surrounding neurons, in interconnecting strands
Fig 4. Expression of TrkB mRNA in juvenile mouse small intestine after antibiotic treatment-induced dysbiosis.
(A, D) RT-PCR quantification of TrkB transcripts in preparations of the mouse small intestine mucosa (A) and
mucosa-deprived whole wall (D) obtained from control (CTR, empty bars) and antibiotic treated mice (ABX, black
bars). Values are mean±S.E.M. of 10 experiments of the percentage variation of relative gene expression with respect to
values obtained in CTR animals. The relative gene expression was determined by comparing 2-ΔΔCt values normalized
to β-actin. Levels of expression of the native TrkB protein (B,E) and the phosphorylated active form at Tyr816 (pTrkB)
(C,F) analyzed in the mucosa (B,C) and mucosa-deprived whole wall (E,F) of the mouse small intestine obtained from
CTR (empty bars) and ABX-treated animals (black bars). Blots representative of immunoreactive bands for TrkB,
pTrkB and β-actin in the different experimental conditions are reported on top of each panel. Samples (200 μg) were
electrophoresed in SDS-8% polyacrylamide gels. Numbers at the margins of the blots indicate relative molecular
weights of the respective protein in kDa. Values are expressed as mean±SEM of 5 experiments of the ratio x1000 of the
optical density (O.D.) of TrkB vs β-actin in CTR and in ABX-treated preparations. �P<0.05 and ���P<0.001 vs CTR
animals by unpaired Student’s t test.
https://doi.org/10.1371/journal.pone.0212856.g004
Fig 5. Effect of antibiotic treatment on TrkB distribution in juvenile mouse small intestine LMMP whole-mount preparations.
Representative confocal microphotographs showing co-staining of TrkB (green) and HuC/D (pan-neuronal marker, red) in LMMPs obtained
from CTR (A-C) and ABX-treated mice (D-F). In LMMPs obtained from both CTR and ABX-treated mice TrkB stained the soma of both
large and medium neurons with an ovoidal shape (arrow). TrkB immunoreactivity was also found in discontinuous prolongations
surrounding neurons and in the interconnecting fibres between ganglia (asterisk). In CTR preparations, TrkB faintly stained the soma of few
neurons. After antibiotic treatment, the number of myenteric neurons staining for TrkB was significantly higher than in CTR (D-E). Bars:
50 μm. (G) Percentage of TrkB immunoreactive myenteric neurons in small intestine of CTR and ABX-treated mice. Values are given as
mean ± SEM of at least 20 fields for each intestinal region. P<0.001 vs CTR animals by unpaired Student’s t test.
https://doi.org/10.1371/journal.pone.0212856.g005
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between ganglia and in bundles of fibres running along the longitudinal smooth muscle (Fig 5
panels A-C and D-F). After antibiotic treatment, a significant [29.40±1.58%, (n = 21)
p<0.001) increase in the number of TrkB-IR myenteric neurons was observed with respect to
preparations obtained from CTR mice (Fig 5, panels D, F and G). In whole-mount LMMP
preparations obtained from both CTR and ABX-treated mice TrkB-IR neurons co-stained
with SP (Fig 6, panels A-C). SP immunoreactivity was also detected in varicose fibres sur-
rounding TrkB-IR myenteric neurons (Fig 6, panels A-C). The percentage of TrkB-IR neurons
expressing SP in ABX-treated mice was not significantly different with respect to values
obtained in CTR animals [14.81±4.45%, (n = 18); and 16.67±5.52% (n = 14), respectively;
p = 0.79]. In both CTR and ABX-treated whole-mount preparations TrkB-IR myenteric neu-
rons were also immunoreactive to CGRP (Fig 6, panels D-F). CGRP immunoreactivity was
found in the soma and nucleus of TrkB-IR neurons as well as in varicose fibres surrounding
TrkB-IR neurons (Fig 6, panels D-F). In CTR preparations, 16.67±5.69% (n = 16) of TrkB-IR
myenteric neurons was immunoreactive to CGRP. This percentage significantly increased in
preparations obtained from ABX-treated animals [42.86±4.68% (n = 20); p<0.001].
BDNF and TrkB mRNA and protein levels in the hippocampus of
antibiotic treated mice
In the hippocampus of ABX-treated mice, BDNF and TrkB mRNA levels were unchanged
(p = 0.071 and p = 0.876, respectively) with respect to CTR (Fig 7 panels A and C). In contrast,
both BDNF and TrkB protein levels were significantly lower in the hippocampus of ABX-
Fig 6. Relationship between TrkB, SP and CGRP immunoreactivity in juvenile mouse small intestine myenteric ganglia. (A-C) Representative
micrographs of mouse small intestine LMMP whole-mount preparations obtained from ABX-treated mice showing co-localization of TrkB and SP.
TrkB immunoreactivity was found in the soma of a population of SP-IR expressing neurons (arrows). Some TrkB myenteric neurons were surrounded
by varicose SP-IR fibres (asterisk). (D-F) Representative micrographs of mouse small intestine LMMP whole-mount preparations obtained from ABX-
treated mice showing co-localization of TrkB and CGRP. CGRP-IR was found in the soma (arrows) and nucleus (arrowhead) of TrkB-IR myenteric
neurons. TrkB-IR myenteric neurons were surrounded by varicose CGRP-IR fibres (asterisk). Bars: 25 μμm.
https://doi.org/10.1371/journal.pone.0212856.g006
Dysbiosis upregulates BDNF and TrkB expression in adolescent mice gut
PLOS ONE | https://doi.org/10.1371/journal.pone.0212856 February 22, 2019 10 / 20
treated mice (p<0.05 for both proteins) than in CTR (Fig 7 panels B and D). To investigate
the pattern of distribution of BDNF and TrkB, we performed fluorescent immunohistochemi-
cal staining for both proteins in hippocampal slices of CTR and ABX-treated mice. In the hip-
pocampus of both CTR and ABX-treated animals, BDNF and TrkB stained the CA1-CA3 and
dentate gyrus (DG) subregions. However, after ABX treatment, BDNF staining decreased in
the CA3 subregion (Fig 8, panels E,F), while TrkB staining was reduced in the DG subregion
(Fig 8, panels G,H).
Fig 7. Expression of BDNF and TrkB in juvenile mouse hippocampus after antibiotic treatment-induced dysbiosis. (A, C) RT-PCR quantification of
BDNF (A) and TrkB (C) transcripts in the mouse hippocampus obtained from control (CTR, empty bars) and antibiotic treated (ABX, black bars). Values are
mean±S.E.M. of 5 experiments of the percentage variation of relative gene expression with respect to values obtained in CTR animals. The relative gene
expression was determined by comparing 2-ΔΔCt values normalized to β-actin. (B, D) BDNF (B) and TrkB (D) protein expression levels analyzed in the
hippocampus obtained from CTR (empty bars) and ABX-treated animals (black bars). Blots representative of immunoreactive bands for TrkB and α-tubulin in
the different experimental conditions are reported on top of each panel. Samples (200 μg) were electrophoresed in SDS-8% polyacrylamide gels. Numbers at the
margins of the blots indicate relative molecular weights of the respective protein in kDa. Values are expressed as mean±S.E.M. of at least 5 experiments of the
ratio x1000 of the optical density (O.D.) of BDNF and TrkB vs α-tubulin in CTR and in ABX-treated preparations. �P<0.05 vs CTR animals by unpaired
Student’s t test.
https://doi.org/10.1371/journal.pone.0212856.g007
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BDNF and TrkB mRNA and protein levels in the prefrontal cortex of
antibiotic-treated mice
In the prefrontal cortex of ABX-treated animals, BDNF and TrkB mRNA levels remained
unchanged (p = 0.489 and p = 0.844, respectively) with respect to values obtained in CTR mice
(Fig 9, panels A and C). BDNF and TrkB protein levels were also unchanged in the prefrontal
cortex of ABX-treated mice (p = 0.37 and p = 0.45, respectively) (Fig 9 panels B and D).
Immunostaining for both BDNF and TrkB in the prefrontal cortex of ABX-treated mice did
not display significant differences with respect to that observed in CTR animals (Fig 9 panels
E-F; G-H).
Discussion
In this study, we provide evidence that a 2-week antibiotic treatment carried out in juvenile
mice induces changes in the expression of BDNF and of its high affinity receptor, TrkB, in
both the ENS and CNS. However, such alterations are different along the gut-brain axis, since
BDNF and TrkB levels are up-regulated in the ENS, downregulated in the hippocampus and
unmodified in the prefrontal cortex, suggesting that dysbiosis may predispose to regionally dif-
ferentiated effects on BDNF signaling. The observed changes are closely superimposable to
BDNF alterations observed in animal models of IBS and IBS patients alike, suggesting that an
antibiotic treatment in adolescence may predispose to functional gut disorders later in life
[13,39]. A two-week course of high-dose, broad-spectrum, poorly-absorbable antibiotics is a
cost-effective model to characterize the many effects of gut dysbiosis on ENS and CNS struc-
ture and function, as shown previously by us and others [3,31,40,41]. However, we have
recently reported that ABX treatment in juvenile mice determines a marked reduction in bac-
terial loads in mouse feces [41] and, consistent with previous observations, the faded commen-
sal stimulation impacts gut neuromuscular function, brain anxiety and cognitive behaviors as
well as key neuroimmune modulators of gut-brain dialogue in a manner comparable to that
described in germ-free mice [42].
Fig 8. Distribution of BDNF and TrkB in juvenile hippocampus of CTR and ABX-treated mice. Fluorescence
microscopy images showing green BDNF and TrkB immunostaining in panoramic images taken from CTR (A,C) and
ABX-treated (B,D) mice, counterstained with DAPI (blue) (bars: 500 μm). Panels E,F represent higher magnifications
of the CA3 subregion, showing a reduced immunostaining for BDNF (green) counterstained with DAPI (blue), in
preparations obtained from ABX-treated mice (F) with respect to CTR (E) (bars: 25 μm). Higher magnification
microscopy images showing green TrkB immunostaining in the dentate gyrus (DG) subregion of CTR (G) and ABX-
treated (H) mice, counterstained with DAPI (blue) (bars: 25 μm). Panels I, L, M, N represent negative controls for each
experimental group. (Bars in I, L: 500 μm; bars in M, N: 50 μm).
https://doi.org/10.1371/journal.pone.0212856.g008
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In analogy with the CNS, in the ENS, BDNF is a target-derived growth factor involved in
neuronal development and survival during ontogenesis [15,43,44], but may also act as an excit-
atory neurotransmitter/neuromodulator, and is involved in the rearrangement of enteric neu-
ronal circuitries, both in physiological conditions and in disease states, such as IBS [23,25,29].
This role is consistent with the presence of BDNF and TrkB immunoreactivity in juvenile
mouse myenteric neurons, as previously demonstrated in the human and adult mouse gut
[42,45]. In the small intestine of juvenile control mice, the number of myenteric neurons stain-
ing for both BDNF and TrkB was relatively low, and increased significantly after antibiotic
treatment-induced dysbiosis. Accordingly, in mucosa-deprived intestinal wall segments of
ABX-treated mice, both BDNF and TrkB mRNA and protein levels were up-regulated.
Enhancement of BDNF and TrkB expression in the colonic muscularis propria containing the
myenteric plexus was also observed in a rat model of chronic stress, inducing IBS symptoms
[45]. We have recently demonstrated that in the juvenile mouse gut, microflora disruption is
associated with important morphological and functional changes in the ENS [29]. From this
standpoint, we cannot exclude that the increased expression of both BDNF and TrkB in the
neuromuscular compartment may contribute to neuronal adaptation to dysbiosis. This
hypothesis is strengthened by the demonstration of an augmented expression of the activated
TrkB receptor, phosphorylated at Tyr816. BDNF, by binding to TrkB induces the receptor
dimerization and autophosphorylation of tyrosine residues, including Tyr816, which is funda-
mental for BDNF-mediated structural and functional neuronal plasticity [46,47]. In the enteric
microenvironment of the human and rodent gut, epithelial mucosal cells represent an
Fig 9. Expression of BDNF and TrKB in juvenile mouse prefrontal cortex (PFC) after antibiotic treatment-
induced dysbiosis. (A, C) RT-PCR quantification of BDNF (A) and TrkB (C) transcripts in the mouse PFC obtained
from control (CTR, empty bars) and antibiotic treated (ABX, black bars). Values are mean±S.E.M. of 7 experiments of
the percentage variation of relative gene expression with respect to values obtained in CTR animals. The relative gene
expression was determined by comparing 2-ΔΔCt values normalized to β-actin. (B, D) BDNF (B) and TrkB (D) protein
expression levels analyzed in the PFC obtained from CTR (empty bars) and ABX-treated animals (black bars). Blots
representative of immunoreactive bands for BDNF and TrkB and α-tubulin in the different experimental conditions
are reported on top of each panel. Samples (200 μg) were electrophoresed in SDS-8% polyacrylamide gels. Numbers at
the margins of the blots indicate relative molecular weights of the respective protein in kDa. Values are expressed as
mean±S.E.M. of 5 experiments of the ratio x1000 of the optical density (O.D.) of BDNF and TrKB vs α-tubulin in CTR
and in ABX-treated preparations. (E-H) Fluorescence microscopy images showing immunostaining for BDNF (green,
Panels E,F) and for TrkB (green, G,H) in the prefrontal cortex of CTR and ABX-treated mice counterstained with
DAPI (blue). Bars: 50 μm.
https://doi.org/10.1371/journal.pone.0212856.g009
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important non-neuronal source of BDNF, playing a paracrine role by stimulating enteric
reflexes, including peristalsis [24,25,45,48]. In the juvenile mouse small intestine mucosa, both
BDNF and TrkB mRNAs and proteins were detected and their expression was upregulated
after antibiotic treatment. High levels of BDNF and TrkB were found in the mucosal layer of
mouse and rat models of IBS [25,45] as well as in the colonic mucosa of IBS patients [39]. In
mice, intracolonic administration of fecal surnatants from IBS patients enhanced mucosal
neurotrophin release and positively correlated with increased expression of TrkB and glial
markers on mucosal enteric glial cells, which represent another source of BDNF in the gut
[25]. Animals developed visceral hypersensitivity to colorectal distension, involving activation
of an enteric glial cell-mediated connection between mucosal signals and enteric neurons via
the BDNF-TrkB signaling. In our model, upregulation of enteric glial cells markers and alter-
ations in the myenteric glial network was observed [31] suggesting the occurrence of a cross-
talk between enteric glial cells and myenteric neurons, via BDNF-TrkB signaling, also in the
small intestine of juvenile dysbiotic mice.
From a functional view point, BDNF exerts a facilitatory modulation on both motor and
sensory gut functions via TrkB activation [27,49]. Administration of either human recombi-
nant BDNF or a BDNF analog to both healthy human subjects and patients with chronic con-
stipation accelerated colonic motility and increased stool frequency [23]. In the rat colon,
endogenous BDNF favored peristalsis in a stimulus-dependent manner during mucosal strok-
ing, and this effect was significantly reduced in heterozygotic (BDNF+/-) mice [24]. The excit-
atory effect of BDNF on gut motor function is mainly indirect, caused by the neurotrophin-
induced release of other excitatory neurotransmitters, such as SP and CGRP [24,45]. This indi-
rect action was substantiated by the evidence that addition of a monoclonal antibody to TrkB
could reduce SP- and CGRP-induced contractions in the mouse ileum and distal colon longi-
tudinal muscle [50]. Accordingly, in primary cultures of guinea pig myenteric plexus, BDNF
promoted synaptic vesicle cluster density, via TrkB receptor activation, and enhanced the
release of SP and CGRP [51]. In our study, as demonstrated in the rat colon [45], some popula-
tions of BDNF- or TrkB-immunoreactive myenteric neurons were also stained for SP, and
SP-containing fibers were found in close proximity of neurons expressing BDNF and TrkB
immunoreactivity. A similar co-staining was also found between subpopulations of BDNF-,
TrkB- and CGRP-immunoreactive myenteric neurons. Overall, these observations are highly
suggestive for the existence of a close interplay between the BDNF-TrkB signaling pathway
and tachykinergic and CGRP-mediated neurotransmission, also in the juvenile mouse small
intestine. The increased co-expression of BDNF and TrkB with both SP and CGRP observed
after dysbiosis, further strengthens this hypothesis, although we cannot exclude that other
neurotransmitter pathways may be related to perturbations of BDNF levels [17], such as gluta-
matergic NMDA receptors, which are highly expressed within the ENS [52,53]. Since the
tachykinergic excitatory transmission to longitudinal smooth muscle of the juvenile mice
small intestine is enhanced after chronic antibiotic treatment [29], we cannot exclude that
such facilitation may be sustained, at least in part, by BDNF and TrkB signaling up-regulation.
In agreement with this hypothesis, in a rat model of IBS, expression of endogenous BDNF and
TrkB increased, and such enhancement favoured SP-mediated contractions of colonic circular
muscle, contributing to the development of hypermotility [45].
As a neurotransmitter/neuromodulator, BDNF released from dorsal root ganglia plays a
fundamental role in the modulation of chronic pain conditions caused by peripheral inflam-
matory responses [54]. Recently, BDNF was shown to modulate visceral hypersensitivity,
which represents a crucial mechanism underlying visceral hypersensitivity in IBS. Visceral
hypersensitivity is generated from disturbances in pain perception both in higher brain regions
and in peripheral sensory pathways, including intrinsic primary afferents in the gut [52,55].
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Heterozygous BDNF+/- mice developed lower colonic nociception under both control condi-
tions and after trinitrobenzesulfonic acid-induced colitis [29]. Enhanced BDNF expression in
the mucosa of IBS patients significantly correlated with the degree of abdominal pain and with
alterations in nerve fibers innervating the mucosa [39]. Co-localization of BDNF with CGRP,
which is a marker of primary afferent neurons in the mouse small intestine [56], indicates that
BDNF may also influence intrinsic primary afferent pathways modulating visceral sensitivity
in the juvenile mouse small intestine. Interestingly, in primary cultures of guinea pig myenteric
ganglia, BDNF is co-stored with CGRP neurons expressing the vanilloid receptor TRPV1, and
is consistent with the co-localization of BDNF and CGRP in sensory neurons of the dorsal
root ganglia [28,57].
Overall, the changes observed in enteric BDNF-TrkB signaling after antibiotic-induced
microflora depletion in the juvenile mouse small intestine share many similarities with the
alterations of BDNF signaling, previously observed in animal models of IBS and in IBS
patients. IBS is a functional GI disease, displaying comorbidity with psychiatric disorders and
is associated with anxiety and mood disorders [58]. In this study, we evaluated the occurrence
of changes in BDNF and TrkB expression in two CNS regions, such as the hippocampus and
prefrontal cortex, which are associated with development of altered behavioral patterns, stress
responses and anxiety [9,59]. Several studies suggest that the GI microbiota may influence
behavior by modulating BDNF production in the CNS. Young adult GF mice showed behav-
ioral anomalies associated with altered levels of several biomarkers, including BDNF, in the
amygdala and hippocampus and cingulate cortex [20,21]. Mice undergoing a massive antibi-
otic treatment from weaning onwards developed an altered behavioral phenotype character-
ized by impairment of cognitive functions later in life, which was paralleled by reduced BDNF
levels in the hippocampus [22]. Accordingly, in this study, the same antibiotic treatment
induced a reduction of BDNF and TrkB expression levels in the hippocampus suggesting an
overall downregulation of the neurotrophin signaling pathway in this CNS region. In particu-
lar, a marked reduction of BDNF staining was observed in the CA3 subregion, while TrkB
expression was lower in the DG subregion of dysbiotic mice. Interestingly, in a recent paper,
CA3 pyramidal hippocampal neuron activity was significantly reduced in dysbiotic mice and
correlated with reduced BDNF hippocampal levels [60]. These observations are all the more
interesting, since, alterations in both the morphology and function of hippocampal CA3 pyra-
midal and DG granular neurons, as well as changes in the hippocampal BDNF-TrkB pathway,
are associated with stress and depression [61,62]. In contrast, the antibiotic treatment did not
modify BDNF and TrkB expression in the prefrontal cortex, as suggested by both biomolecular
and immunohistochemistry data. These data may suggest that the hippocampus, more than
the prefrontal cortex, represents a target region in microbiota-mediated modulation of brain
development during adolescence [22]. Furthermore, our results suggest that changes in the
saprophytic microflora have different consequences on the regulation of BDNF expression
along the gut-brain axis. This region-specific tuning of BDNF expression may contribute to
alter specific responses in the ENS (i.e. motility and sensitivity) and in the brain, fostering the
development of GI disorders, characterized by psychiatric comorbidity ad alterations in the
gut microbiota over time, such as IBS [63].
Conclusions
In summary, the present data suggest that a dysbiosis induced by a massive antibiotic treat-
ment during adolescence may alter BDNF and TrkB expression both in the ENS and CNS,
although with different outcomes in the two nervous systems, later in life. We cannot exclude
that these molecular changes may contribute to alter specific neurotransmitter pathways,
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involved in the development of functional gut diseases, such as IBS. These results further
strengthen the concept that appropriate manipulation of the gut microbiome during adoles-
cence, may reduce the probability of developing severe disorders that could affect the gut and
the CNS later. This is all the more interesting in view of the worldwide increasing incidence of
functional gastrointestinal disorders affecting the adolescent and young population [64,65].
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